0001192482-19-000335.txt : 20190813
0001192482-19-000335.hdr.sgml : 20190813
20190813164235
ACCESSION NUMBER: 0001192482-19-000335
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190809
FILED AS OF DATE: 20190813
DATE AS OF CHANGE: 20190813
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Brannelly Paul
CENTRAL INDEX KEY: 0001394936
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37372
FILM NUMBER: 191021260
MAIL ADDRESS:
STREET 1: C/O KARYOPHARM THERAPEUTICS INC.
STREET 2: 2 MERCER ROAD
CITY: NATICK
STATE: MA
ZIP: 01760
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: COLLEGIUM PHARMACEUTICAL, INC
CENTRAL INDEX KEY: 0001267565
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: VA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 TECHNOLOGY CENTER DRIVE
CITY: STOUGHTON
STATE: MA
ZIP: 02072
BUSINESS PHONE: 781-713-3699
MAIL ADDRESS:
STREET 1: 100 TECHNOLOGY CENTER DRIVE
CITY: STOUGHTON
STATE: MA
ZIP: 02072
FORMER COMPANY:
FORMER CONFORMED NAME: COLLEGIUM PHARMACEUTICAL INC
DATE OF NAME CHANGE: 20031020
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2019-08-09
0001267565
COLLEGIUM PHARMACEUTICAL, INC
COLL
0001394936
Brannelly Paul
C/O COLLEGIUM PHARMACEUTICAL, INC.
100 TECHNOLOGY CENTER DRIVE
STOUGHTON
MA
02072
0
1
0
0
Executive Vice President & CFO
Common Stock
2019-07-26
5
A
0
797
9.04
A
152904
D
Common Stock
2019-08-09
4
F
0
1517
11.24
D
151387
D
Shares acquired under the Collegium Pharmaceutical, Inc. 2015 Employee Stock Purchase Plan in a transaction exempt under both Rule 16b-3(d) and Rule 16b-3(c).
Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.
/s/ Paul Brannelly
2019-08-13